Luciferase Assay Negative Control

Lab Reagents

Human IgG antibody Laboratories manufactures the luciferase assay negative control reagents distributed by Genprice. The Luciferase Assay Negative Control reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Luciferase products are available in stock. Specificity: Luciferase Category: Assay Group: Negative Control

Negative Control information

Recombinant EBV Negative Control Extract

VAng-Lsx0110-1mL 1 mL
EUR 397.2
Description: EBV Negative Control Extract, recombinant protein from human cells.

Recombinant EBV Negative Control Extract

VAng-Lsx0110-25mL 25 mL
EUR 5668.8
Description: EBV Negative Control Extract, recombinant protein from human cells.

EZSolution? Q-VD-OPh, Negative Control

1174-1
EUR 248.4

Mouse precursor Scramble negative control construct

MMIR-000-PA-1 Bacterial Streak
EUR 597.6

Anti-IgG1 Negative Control Antibody antibody

STJ16100881 1 mL
EUR 573.6

OxiSelect Comet Assay Control Cells

STA-354 1 set
EUR 303.6
Description: OxiSelect Comet Assay Control Cells are a set of two cell lines that serve as a positive control (Etoposide-treated) and a negative control (untreated) respectively.

NATtrol Norovirus Negative Control (6 x 0.125mL)

NATROTA-6MC 6 x 0.125mL
EUR 255.94
Description: Please contact Gentaur in order to receive the datasheet of the product.

Mouse negative control sera (purified) for IHC

NCM802M 7 ml
EUR 238.8

NATtrol BV Negative Control (6 X 0.15mL)

NATBVNEG-BD 6 X 0.15mL
EUR 345.79
Description: Please contact Gentaur in order to receive the datasheet of the product.

ODN 2006-Type B (human, Negative Control)

VAdv-Ly0070 5 mg
EUR 4332
Description: ODN 2006-Type B, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 1668-Type B (murine, Negative Control)

VAdv-Ly0071-1mg 1 mg
EUR 1528.8
Description: ODN 1668-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 1668-Type B (murine, Negative Control)

VAdv-Ly0071-5mg 5 mg
EUR 4332
Description: ODN 1668-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2088-Type A (murine, Negative Control)

VAdv-Ly0072-1mg 1 mg
EUR 1528.8
Description: ODN 2088-Type A, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2088-Type A (murine, Negative Control)

VAdv-Ly0072-5mg 5 mg
EUR 4332
Description: ODN 2088-Type A, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 1826-Type B (murine, Negative Control)

VAdv-Ly0074 5 mg
EUR 4332
Description: ODN 1826-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2216-Type A (human, Negative Control)

VAdv-Ly0075-1mg 1 mg
EUR 1528.8
Description: ODN 2216-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2216-Type A (human, Negative Control)

VAdv-Ly0075-5mg 5 mg
EUR 4332
Description: ODN 2216-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.